| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 12, 2026 | Lingxin Qiaoshou | $217.3M Series B | Daode Investment, Prosperity Investment | Caixin Capital, Chengzhu Investment Management, Cloud Capital, D.T. Lake Equity Investment, Eastern Epic Capitals, Nova Star, Wise Road Capital, Yingyuan Puyuan Fund, Zhonghe Capital |
| Feb 2, 2026 | Deep Intelligent Pharma | $60.0M Series D | — | CDH Investments, Jinyi Capital, Kaitai Capital, Trustar Capital |